DiCara, DM, Chirgadze, DY, Pope, AR, Karatt-Vellatt, A, Winter, A, Slavny, P, van den Heuvel, J, Parthiban, K, Holland, J, Packman, LC, Mavria, G, Hoffmann, J, Birchmeier, W, Gherardi, E and McCafferty, J (2017) Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain. Scientific Reports, 7 (1). 9000 - ?. ISSN 2045-2322

[thumbnail of Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain.pdf]
Preview
Text
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain.pdf - Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview

Abstract

The growth and motility factor Hepatocyte Growth Factor/Scatter Factor (HGF/SF) and its receptor, the product of the MET proto-oncogene, promote invasion and metastasis of tumor cells and have been considered potential targets for cancer therapy. We generated a new Met-blocking antibody which binds outside the ligand-binding site, and determined the crystal structure of the Fab in complex with its target, which identifies the binding site as the Met Ig1 domain. The antibody, 107_A07, inhibited HGF/SF-induced cell migration and proliferation in vitro and inhibited growth of tumor xenografts in vivo. In biochemical assays, 107_A07 competes with both HGF/SF and its truncated splice variant NK1 for MET binding, despite the location of the antibody epitope on a domain (Ig1) not reported to bind NK1 or HGF/SF. Overlay of the Fab-MET crystal structure with the InternalinB-MET crystal structure shows that the 107_A07 Fab comes into close proximity with the HGF/SF-binding SEMA domain when MET is in the "compact", InternalinB-bound conformation, but not when MET is in the "open" conformation. These findings provide further support for the importance of the "compact" conformation of the MET extracellular domain, and the relevance of this conformation to HGF/SF binding and signaling.

Item Type: Article
Additional Information: This is the final published version of the article (version of record). It first appeared online via Nature Publishing Group at https://doi.org/10.1038/s41598-017-09460-2 - please refer to any applicable terms of use of the publisher.
Subjects: Q Science > QD Chemistry > QD415 Biochemistry
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Natural Sciences > School of Chemical and Physical Sciences
Related URLs:
Depositing User: Symplectic
Date Deposited: 07 Sep 2017 09:46
Last Modified: 07 Sep 2017 09:47
URI: https://eprints.keele.ac.uk/id/eprint/3997

Actions (login required)

View Item
View Item